MannKind Reports Positive Phase 1b Results for Inh...
Category : Clinical Trial Update 31 July 2026Study Shows Favorable Safety Profile for Inhaled Nintedanib in IPF Patients MannKind Corporation...
Clinical Trial Update
ViiV Healthcare Shares New HIV Treatment and Preve...
Category : Clinical Trial Update 31 July 2026New Studies Highlight Progress in Long-Acting HIV Care GSK plc announced that ViiV Healthcare pre...
ProMIS Reports Positive Interim Phase 1b Results f...
Category : Clinical Trial Update 30 July 2026Early Clinical Data Shows Encouraging Safety Profile ProMIS Neurosciences Inc., a clinical-stage...
Ascletis’ ASC37 Shows Strong Weight Loss Results i...
Category : Clinical Trial Update 28 July 2026Next-generation triple peptide agonist outperformed tirzepatide in obese mice Ascletis Pharma Inc...
NewAmsterdam’s Obicetrapib Gets Positive CHMP Opin...
Category : Clinical Trial Update 27 July 2026Ubeslo and Evlarco move closer to potential approval for patients with high LDL-C NewAmsterdam Ph...
Latest Newsletter Post
-
ViiV Healthcare Shares New HIV Trea..
31 July 2026
-
Kaigene Licenses Autoimmune Drug Ca..
31 July 2026
-
MannKind Reports Positive Phase 1b..
31 July 2026
-
ProMIS Reports Positive Interim Pha..
30 July 2026
-
Bain Capital to Acquire Vitabiotics..
30 July 2026
